Search this site
Embedded Files
Skip to main content
Skip to navigation
Reumáti.co
Inicio
Artritis infecciosa
Preguntas
Artritis reumatoide
Preguntas
Artropatías microcristalinas
Preguntas
Esclerosis sistémica
Espondiloartritis
Preguntas
Exploración física
Fibromialgia
Preguntas
Lupus
Preguntas
Manifestaciones reumaticas
Preguntas
Miopatías
Preguntas
Osteoartritis
Osteoporosis
Preguntas
Pediatría
Preguntas
Síndrome de Sjogren
Preguntas
Vasculitis
Preguntas
Aprenda más
Quienes somos?
Teorias educacionales
Recursos adicionales
Contáctenos
Reumáti.co
Artropatías microcristalinas
Referencias
Jordan, K. Up-to-date management of gout. Curr Opin Rheumatol. 2012; 23(2): 145-51.
Richett P, Bardin T. Gout. Lancet 2010;23:318-28.
Pascual E, et. al, Synovial fluid analysis for crystals. Curr Opin Rheumatol. 2011; 23: 161-9.
Zhang W, et. al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006; 65: 1301-11.
Zhang W, et.al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006; 65: 1312-24.
Zhang W, et. al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011; 70: 563-70.
Zhang W. et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70:571-5.
Tuhina Neogi, Gout. N Engl J Med 2011; 364:443-452
Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010;62:1060-1068
2012 American College of Rheumatology Guidelines for Management of Gout Part I: Systematic Non-pharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia
Dinesh Khanna
,1,*
John D. FitzGerald
,2,*
Puja P. Khanna
,1,*
Sangmee Bae
,2
Manjit Singh
,3
Tuhina Neogi
,4
Michael H. Pillinger
,5
Joan Merill
,6
Susan Lee
,7
Shraddha Prakash
,2
Marian Kaldas
,2
Maneesh Gogia
,2
Fernando Perez-Ruiz
,8
Will Taylor
,9
Frédéric Lioté
,10
Hyon Choi
,4
Jasvinder A. Singh
,22
Nicola Dalbeth
,11
Sanford Kaplan
,12
Vandana Niyyar
,13
Danielle Jones
,13
Steven A. Yarows
,14
Blake Roessler
,1
Gail Kerr
,15
Charles King
,16
Gerald Levy
,17
Daniel E. Furst
,2
N. Lawrence Edwards
,18
Brian Mandell
,19
H. Ralph Schumacher
,20
Mark Robbins
,21
Neil Wenger
,2 and
Robert Terkeltaub
7
2012 American College of Rheumatology Guidelines for Management of Gout Part II: Therapy and Anti-inflammatory Prophylaxis of Acute Gouty Arthritis
Dinesh Khanna
,1,*
Puja P. Khanna
,1,*
John D. FitzGerald
,2,*
Manjit K. Singh
,3
Sangmee Bae
,2
Tuhina Neogi
,4
Michael H. Pillinger
,5
Joan Merill
,6
Susan Lee
,7
Shraddha Prakash
,2
Marian Kaldas
,2
Maneesh Gogia
,2
Fernando Perez-Ruiz
,8
Will Taylor
,9
Frédéric Lioté
,10
Hyon Choi
,4
Jasvinder A. Singh
,11
Nicola Dalbeth
,12
Sanford Kaplan
,13
Vandana Niyyar
,14
Danielle Jones
,14
Steven A. Yarows
,15
Blake Roessler
,1
Gail Kerr
,16
Charles King
,17
Gerald Levy
,18
Daniel E. Furst
,2
N. Lawrence Edwards
,19
Brian Mandell
,20
H. Ralph Schumacher
,21
Mark Robbins
,22
Neil Wenger
,2 and
Robert Terkeltaub
Report abuse
Report abuse